Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and in situ intestinal perfusion
Repaglinide-loaded nanostructured lipid carriers (REP-NLCs) with different particle sizes were successfully designed and prepared to investigate the permeation and absorption ability by in situ single-pass intestinal perfusion (SPIP) study and pharmacokinetics. Both of the formulations prepared by s...
Main Authors: | Lei Wu, Lin Zhao, Xitong Su, Peng Zhang, Guixia Ling |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2019.1689313 |
Similar Items
-
Pharmacokinetic Investigation to Study the In Vivo Bioavailability of Thiolated Chitosan Based Repaglinide Buccal Tablets
by: Raja Navamanisubramanian, et al.
Published: (2020-12-01) -
Determination of repaglinide in human plasma by high-performance liquid chromatography–tandem mass spectrometry
by: Jie Zhang, et al.
Published: (2011-06-01) -
Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
by: Mohammed Elmowafy, et al.
Published: (2021-09-01) -
Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea
by: Kazuno Omori, et al.
Published: (2019-03-01) -
The Effect of Repaglinide on Polycystic Ovary Induced by Testosterone Enanthate in NMRI Mice
by: Fariba Noori, et al.
Published: (2017-02-01)